Early safety check for experimental drug emraclidine in seniors

NCT ID NCT07219030

Recruiting now Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study is testing an experimental drug called emraclidine in 40 healthy adults aged 65 and older. Researchers want to see how the drug moves through the body and whether it causes any side effects. Participants will receive either emraclidine or a placebo pill. This study does not aim to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Emraclidine

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEER

Contacts and locations

Locations

Acpru /Id# 276996
RECRUITING

Grayslake, Illinois, 60030, United States
Altasciences Clinical Los Angeles /ID# 276854
RECRUITING

Cypress, California, 90630, United States
Clinical Pharmacology Of Miami /ID# 276856
RECRUITING

Miami, Florida, 33172, United States
K2 Medical Research, LLC /ID# 276636
RECRUITING

Maitland, Florida, 32751, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.